ICNC2018 Abstracts & Symposia Proposals, ICNC 2014

Font Size: 
Spinal Muscular Atrophy life span
Alexandra Prufer de Q. C. Araujo, Giuseppe Mario Carmine Carmine Pastura, Marlos Melo Martins, Aline Chacon Pereira, Roberta da Silva Mendonça Thurler, Sheyla Ribeiro Magalhães, Alessandra Maria Rocha Rodrigues, Rita Farias de Oliveira, Karen Grazielle Capuano de Sant'Anna, Viviane Romão Soares da Rocha

Building: Bourbon Cataratas Convention Centre, Foz do Iguaçu
Room: Cataratas II
Date: 2014-05-08 03:00 PM – 03:15 PM
Last modified: 2014-02-09

Abstract


Introduction: Spinal Muscular Atrophy (SMA) is one of the most common neuromuscular diseases. In recent years the natural history of this disease has been found to change.

Methods: To describe SMA brazilian children  we adopted the data base information of a global registry. Information input, regarding demografic, motor function , pulmonary, orthopedic complications and molecular tests comes from medical documentation.

Results: This is a ongoing project in line with global registries. At present only the parcial results are described. A total of 46 patients have had their information colected. Ten were classified as SMA type 1, with an age range from 1 to 13 years, 6 boys, feeding by gastrostomy, need for ventilatory support from 11 to 24 hours daily. Only two have died. SMA type 2 is the largest group with 20 pacients, from 2 to 23 years of age, twelve males, either sitting with support or standing with support, scoliosis (36%) and respiratory support (27%) were the main complication in this group. Sixteen type 3 SMA, from age 5 to fifty one, 9 females, either standing or walking, some were overweight and only one had scoliosis and hypoventilation. SMN2 copy number were higher in type 3 (4 or 5 copies), than in type 2 (2 or 3) and type 1 (0 to 2).

Conclusion: As in other countries SMA has nowadays a longer span of life also in Brazil.


Keywords


Spinal Muscular Atrophies of Childhood; Epidemiology

References


1: Gregoretti C, Ottonello G, Chiarini Testa MB, Mastella C, Ravà L, Bignamini E,
Veljkovic A, Cutrera R. Survival of patients with spinal muscular atrophy type 1.
Pediatrics. 2013 May;131(5):e1509-14. doi: 10.1542/peds.2012-2278. Epub 2013 Apr
22. PubMed PMID: 23610208.


2: Werlauff U, Vissing J, Steffensen BF. Change in muscle strength over time in
spinal muscular atrophy types II and III. A long-term follow-up study.
Neuromuscul Disord. 2012 Dec;22(12):1069-74. doi: 10.1016/j.nmd.2012.06.352. Epub
2012 Nov 3. PubMed PMID: 23127961.


3: Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, Oskoui M,
Constantinescu A, Gooch CL, Foley AR, Yang ML, Tawil R, Chung WK, Martens WB,
Montes J, Battista V, O'Hagen J, Dunaway S, Flickinger J, Quigley J, Riley S,
Glanzman AM, Benton M, Ryan PA, Punyanitya M, Montgomery MJ, Marra J, Koo B, De
Vivo DC; Muscle Study Group (MSG); Pediatric Neuromuscular Clinical Research
Network for Spinal Muscular Atrophy (PNCR). Prospective cohort study of spinal
muscular atrophy types 2 and 3. Neurology. 2012 Oct 30;79(18):1889-97. doi:
10.1212/WNL.0b013e318271f7e4. Epub 2012 Oct 17. PubMed PMID: 23077013; PubMed
Central PMCID: PMC3525313.

Conference registration is required in order to view papers.